iRiva Medical

iRiva Medical is a clinical-stage medical device developer targeting chronic conditions through novel neuromodulation therapies. The company leverages a seasoned leadership team with deep expertise in active implantable devices, supported by venture capital partners. While still pre-revenue, iRiva is advancing its technology platforms through development and into early clinical studies, aiming to provide new treatment options for burdensome chronic diseases.

Next-generation implantable neuromodulation technology platforms, potentially integrated with drug delivery systems, for treating chronic diseases.

iRiva competes in the active implantable neuromodulation space, which is dominated by large players like Medtronic, Boston Scientific, and Abbott. It also faces competition from numerous private and public specialty neuromodulation companies (e.g., Nevro, Inspire Medical, CVRx). Its potential differentiation may lie in targeting new disease indications or combining neuromodulation with drug delivery.